Friday, September 08, 2023 9:42:22 AM
You quoted the poster correctly.....
"The remaining drugs have never proven their potential in human trials"
.....and the poster was perfectly correct.
If the Company itself said the following the FDA could have something to say about it and the Rosens (remember them) of the world might as well:
"Brilacidin: Successful and safe trials for 3 different human malady with 3 different administer methods. "
Completion of a Phase 2 trial should only be described as the successful completion of a Phase 2 trial, nothing more and nothing less. Neither Brilacidin nor any other IPIX drug has proven its potential in a human trial.
That poster's language was accurate and you may not have liked the import of it but it was VERY wrong of you to say this:
"Your language is poor:"
Language is important. Proven and potential are words that have meanings that are especially important when it comes to pharmaceuticals.
No matter what it is or who commenced it, I'm against it!
....Groucho
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM